Shift Labs
AcquiredYC W15Seattle, US · Founded 2012 · Delaware corporation · 6 employees · 3 known investors
Shift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings. The platform remotely tracks medication infusion rates and provides data analytics for healthcare providers administering home infusion therapy.
Founders & leadership· Y Combinator alumni (W15)
Shift Labs was founded in 2012 by Beth Kolko.
Investors · 3
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 1 of 3 rounds · 2015–2023
▶Undisclosed amountofferedMar 2023 · Business ServicesRule 506(b)
- Joseph MechlinskiExecutive Officer
- Minimum investment
- $100K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MofferedApr 2022 · Business ServicesRule 506(b)
- Joseph MechlinskiExecutive Officer, Director
- Offering amount
- $1.5M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJul 2015 · 26 investors · Other TechnologyRule 506(b)
- Beth KolkoExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $1K
- First sale
- Mar 2015
- Incorporated
- Corporation, Washington, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapCompanies competing with Shift Labs for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $251.2K |
| U.S. Air ForceAir Force | Phase II | 2019 | $1.5M |
| U.S. Air ForceAir Force | Phase I | 2019 | $49.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Shift Labs do?
- Shift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings. The platform remotely tracks medication infusion rates and provides data analytics for healthcare providers administering home infusion therapy.
- Who founded Shift Labs?
- Shift Labs was founded by Beth Kolko in 2012.
- Who are Shift Labs's investors?
- Shift Labs's investors include Knockout Capital, SGH Capital, Y Combinator.
- How much funding has Shift Labs raised?
- Shift Labs has disclosed $1.2M raised across 1 of its 3 known rounds.
- Where is Shift Labs headquartered?
- Shift Labs is headquartered in Seattle, US.

